Abbott Laboratories (ABT) CEO Miles White on Q3 2019 Results - Earnings Call Transcript

Oct. 16, 2019 2:42 PM ETAbbott Laboratories (ABT) StockABT
SA Transcripts
153.96K Followers

Q3: 2019-10-16 Earnings Summary

EPS of $0.84 misses by $0.00
 | Revenue of $8.08B (5.49% Y/Y) misses by $28.15M

Abbott Laboratories. (NYSE:ABT) Q3 2019 Results Earnings Conference Call October 16, 2019 9:00 AM ET

Company Participants

Scott Leinenweber - VP, IR, Licensing and Acquisitions
Miles White - Chairman and CEO
Robert Ford - President and COO
Brian Yoor - EVP, Finance and CFO

Conference Call Participants

David Lewis - Morgan Stanley
Larry Biegelsen - Wells Fargo
Bob Hopkins - Bank of America
Vijay Kumar - Evercore ISI
Robbie Marcus - JPMorgan
Rick Wise - Stifel
Matt Taylor - UBS

Operator

Good morning and thank you for standing by. Welcome to Abbott’s Third Quarter 2019 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participant’s questions asked during the question-and-answer session, the entire call including the question-and-answer session is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott’s express written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations, Licensing and Acquisitions.

Scott Leinenweber

Good morning and thank you for joining us. With me today are Miles White, Chairman of the Board and Chief Executive Officer; Robert Ford, President and Chief Operating Officer; and Brian Yoor, Executive Vice President, Finance and Chief Financial Officer. Miles will provide opening remarks and Brian will discuss our performance and outlook in more detail. Following their comments, we’ll take your questions.

Before we get started, some statements made today may be forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2019. Abbott cautions that these forward-looking statements are subject to the risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.

Economic, competitive, governmental, technological and other factors that

Recommended For You

About ABT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on ABT